Cargando…

Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey

BACKGROUND: Decisions about the continued need for control measures to contain the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rely on accurate and up-to-date information about the number of people testing positive for SARS-CoV-2 and risk factors for testing positive. Exis...

Descripción completa

Detalles Bibliográficos
Autores principales: Pouwels, Koen B, House, Thomas, Pritchard, Emma, Robotham, Julie V, Birrell, Paul J, Gelman, Andrew, Vihta, Karina-Doris, Bowers, Nikola, Boreham, Ian, Thomas, Heledd, Lewis, James, Bell, Iain, Bell, John I, Newton, John N, Farrar, Jeremy, Diamond, Ian, Benton, Pete, Walker, Ann Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786000/
https://www.ncbi.nlm.nih.gov/pubmed/33308423
http://dx.doi.org/10.1016/S2468-2667(20)30282-6
_version_ 1783632541459152896
author Pouwels, Koen B
House, Thomas
Pritchard, Emma
Robotham, Julie V
Birrell, Paul J
Gelman, Andrew
Vihta, Karina-Doris
Bowers, Nikola
Boreham, Ian
Thomas, Heledd
Lewis, James
Bell, Iain
Bell, John I
Newton, John N
Farrar, Jeremy
Diamond, Ian
Benton, Pete
Walker, Ann Sarah
author_facet Pouwels, Koen B
House, Thomas
Pritchard, Emma
Robotham, Julie V
Birrell, Paul J
Gelman, Andrew
Vihta, Karina-Doris
Bowers, Nikola
Boreham, Ian
Thomas, Heledd
Lewis, James
Bell, Iain
Bell, John I
Newton, John N
Farrar, Jeremy
Diamond, Ian
Benton, Pete
Walker, Ann Sarah
author_sort Pouwels, Koen B
collection PubMed
description BACKGROUND: Decisions about the continued need for control measures to contain the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rely on accurate and up-to-date information about the number of people testing positive for SARS-CoV-2 and risk factors for testing positive. Existing surveillance systems are generally not based on population samples and are not longitudinal in design. METHODS: Samples were collected from individuals aged 2 years and older living in private households in England that were randomly selected from address lists and previous Office for National Statistics surveys in repeated cross-sectional household surveys with additional serial sampling and longitudinal follow-up. Participants completed a questionnaire and did nose and throat self-swabs. The percentage of individuals testing positive for SARS-CoV-2 RNA was estimated over time by use of dynamic multilevel regression and poststratification, to account for potential residual non-representativeness. Potential changes in risk factors for testing positive over time were also assessed. The study is registered with the ISRCTN Registry, ISRCTN21086382. FINDINGS: Between April 26 and Nov 1, 2020, results were available from 1 191 170 samples from 280 327 individuals; 5231 samples were positive overall, from 3923 individuals. The percentage of people testing positive for SARS-CoV-2 changed substantially over time, with an initial decrease between April 26 and June 28, 2020, from 0·40% (95% credible interval 0·29–0·54) to 0·06% (0·04–0·07), followed by low levels during July and August, 2020, before substantial increases at the end of August, 2020, with percentages testing positive above 1% from the end of October, 2020. Having a patient-facing role and working outside your home were important risk factors for testing positive for SARS-CoV-2 at the end of the first wave (April 26 to June 28, 2020), but not in the second wave (from the end of August to Nov 1, 2020). Age (young adults, particularly those aged 17–24 years) was an important initial driver of increased positivity rates in the second wave. For example, the estimated percentage of individuals testing positive was more than six times higher in those aged 17–24 years than in those aged 70 years or older at the end of September, 2020. A substantial proportion of infections were in individuals not reporting symptoms around their positive test (45–68%, dependent on calendar time. INTERPRETATION: Important risk factors for testing positive for SARS-CoV-2 varied substantially between the part of the first wave that was captured by the study (April to June, 2020) and the first part of the second wave of increased positivity rates (end of August to Nov 1, 2020), and a substantial proportion of infections were in individuals not reporting symptoms, indicating that continued monitoring for SARS-CoV-2 in the community will be important for managing the COVID-19 pandemic moving forwards. FUNDING: Department of Health and Social Care.
format Online
Article
Text
id pubmed-7786000
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Author(s). Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-77860002021-01-11 Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey Pouwels, Koen B House, Thomas Pritchard, Emma Robotham, Julie V Birrell, Paul J Gelman, Andrew Vihta, Karina-Doris Bowers, Nikola Boreham, Ian Thomas, Heledd Lewis, James Bell, Iain Bell, John I Newton, John N Farrar, Jeremy Diamond, Ian Benton, Pete Walker, Ann Sarah Lancet Public Health Articles BACKGROUND: Decisions about the continued need for control measures to contain the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rely on accurate and up-to-date information about the number of people testing positive for SARS-CoV-2 and risk factors for testing positive. Existing surveillance systems are generally not based on population samples and are not longitudinal in design. METHODS: Samples were collected from individuals aged 2 years and older living in private households in England that were randomly selected from address lists and previous Office for National Statistics surveys in repeated cross-sectional household surveys with additional serial sampling and longitudinal follow-up. Participants completed a questionnaire and did nose and throat self-swabs. The percentage of individuals testing positive for SARS-CoV-2 RNA was estimated over time by use of dynamic multilevel regression and poststratification, to account for potential residual non-representativeness. Potential changes in risk factors for testing positive over time were also assessed. The study is registered with the ISRCTN Registry, ISRCTN21086382. FINDINGS: Between April 26 and Nov 1, 2020, results were available from 1 191 170 samples from 280 327 individuals; 5231 samples were positive overall, from 3923 individuals. The percentage of people testing positive for SARS-CoV-2 changed substantially over time, with an initial decrease between April 26 and June 28, 2020, from 0·40% (95% credible interval 0·29–0·54) to 0·06% (0·04–0·07), followed by low levels during July and August, 2020, before substantial increases at the end of August, 2020, with percentages testing positive above 1% from the end of October, 2020. Having a patient-facing role and working outside your home were important risk factors for testing positive for SARS-CoV-2 at the end of the first wave (April 26 to June 28, 2020), but not in the second wave (from the end of August to Nov 1, 2020). Age (young adults, particularly those aged 17–24 years) was an important initial driver of increased positivity rates in the second wave. For example, the estimated percentage of individuals testing positive was more than six times higher in those aged 17–24 years than in those aged 70 years or older at the end of September, 2020. A substantial proportion of infections were in individuals not reporting symptoms around their positive test (45–68%, dependent on calendar time. INTERPRETATION: Important risk factors for testing positive for SARS-CoV-2 varied substantially between the part of the first wave that was captured by the study (April to June, 2020) and the first part of the second wave of increased positivity rates (end of August to Nov 1, 2020), and a substantial proportion of infections were in individuals not reporting symptoms, indicating that continued monitoring for SARS-CoV-2 in the community will be important for managing the COVID-19 pandemic moving forwards. FUNDING: Department of Health and Social Care. The Author(s). Published by Elsevier Ltd. 2021-01 2020-12-11 /pmc/articles/PMC7786000/ /pubmed/33308423 http://dx.doi.org/10.1016/S2468-2667(20)30282-6 Text en © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Articles
Pouwels, Koen B
House, Thomas
Pritchard, Emma
Robotham, Julie V
Birrell, Paul J
Gelman, Andrew
Vihta, Karina-Doris
Bowers, Nikola
Boreham, Ian
Thomas, Heledd
Lewis, James
Bell, Iain
Bell, John I
Newton, John N
Farrar, Jeremy
Diamond, Ian
Benton, Pete
Walker, Ann Sarah
Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey
title Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey
title_full Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey
title_fullStr Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey
title_full_unstemmed Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey
title_short Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey
title_sort community prevalence of sars-cov-2 in england from april to november, 2020: results from the ons coronavirus infection survey
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786000/
https://www.ncbi.nlm.nih.gov/pubmed/33308423
http://dx.doi.org/10.1016/S2468-2667(20)30282-6
work_keys_str_mv AT pouwelskoenb communityprevalenceofsarscov2inenglandfromapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey
AT housethomas communityprevalenceofsarscov2inenglandfromapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey
AT pritchardemma communityprevalenceofsarscov2inenglandfromapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey
AT robothamjuliev communityprevalenceofsarscov2inenglandfromapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey
AT birrellpaulj communityprevalenceofsarscov2inenglandfromapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey
AT gelmanandrew communityprevalenceofsarscov2inenglandfromapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey
AT vihtakarinadoris communityprevalenceofsarscov2inenglandfromapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey
AT bowersnikola communityprevalenceofsarscov2inenglandfromapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey
AT borehamian communityprevalenceofsarscov2inenglandfromapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey
AT thomasheledd communityprevalenceofsarscov2inenglandfromapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey
AT lewisjames communityprevalenceofsarscov2inenglandfromapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey
AT belliain communityprevalenceofsarscov2inenglandfromapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey
AT belljohni communityprevalenceofsarscov2inenglandfromapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey
AT newtonjohnn communityprevalenceofsarscov2inenglandfromapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey
AT farrarjeremy communityprevalenceofsarscov2inenglandfromapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey
AT diamondian communityprevalenceofsarscov2inenglandfromapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey
AT bentonpete communityprevalenceofsarscov2inenglandfromapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey
AT walkerannsarah communityprevalenceofsarscov2inenglandfromapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey
AT communityprevalenceofsarscov2inenglandfromapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey